Skip to search.
 BSE Down 0.43% NSE Down 0.57%
Streaming
Ticker Tape: On

Merrimack Pharmaceuticals, Inc. (MACK)

-NasdaqGM

5.11 Down 0.16(3.04%) 23 May 1:30AM

Add to Portfolio
Prev Close:5.27
Open:5.39
Bid:5.00 x 300
Ask:5.50 x 100
1y Target Est:12.60
Beta:1.569
Next Earnings Date:N/A
Day's Range:5.01 - 5.47
52wk Range:4.06 - 11.11
Volume:282,443
Avg Vol (3m):331,219
Market Cap:491.00M
P/E (ttm):N/A
EPS (ttm):-1.02
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for MACK at this time.

Comparison

Symbol% ChgMkt Cap
MACKDown 3.04%491.00M
RHHBYN.MXUp 0.14%2.66T
SHP.LUp 0.94%11.88B
SUNPHARMA.NSUp 0.49%1.04T
GILD.MXDown 0.83%1.06T
» More Competitors

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):9.69
Ex-Dividend Date:N/A
» More Key Statistics

Analysts

Annual EPS Est (Dec-13) :-1.03
Quarterly EPS Est (Jun-13) :-0.27
Mean Recommendation*:1.2
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer in the United States. View More
Company Profile | Industry
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback